Daniel McGrath is a Partner and Solicitor based in London who advises clients on a wide range of intellectual property matters, with a particular focus on contentious life sciences and high-tech work. He has particular experience in biopharmaceutical patent and SPC litigation and has represented clients in some of the most complex technical disputes tried in the English courts.
Qualified as a Solicitor in England & Wales in 2015, he has advised clients in proceedings before the High Court and Court of Appeal and has significant experience of multi-jurisdictional disputes involving teams across Europe, North America, Asia and Australia.
With a keen interest in scientific innovation, Dan is readily able to master highly technical issues and has a strong grasp of the technical and commercial landscape in which his clients operate.
Dan has particular experience in biopharmaceutical patent and SPC litigation. His life sciences work covers antibodies, vaccines, pharmaceutical formulations, small molecules and second medical use products. He also advises on regulatory matters including SPCs, SPCs for plant protection products, paediatric rewards and marketing authorisations.
In the high-tech sector, Dan advises on FRAND and standard essential patent issues, wireless communication systems, software and web technologies. He is recognised for his ability to work effectively with technically complex subject matter, helping clients navigate both the technical and commercial considerations relevant to their disputes and business objectives. His wider experience includes matters involving fire-rated downlights, zip and closure technologies, as well as trade marks, designs, copyright and confidential information.
Dan holds a Postgraduate Diploma in Intellectual Property Law and Practice from the University of Oxford (2016) and a BSc (Hons) in Physics from the University of Durham (2011). He joined Marks & Clerk Law in November 2016 after training and qualifying at a magic circle firm.
Key cases:
Sun Pharma and Almirall v Janssen Biotech
Chugai v UCB
Eli Lilly v Genentech
Merck Sharp & Dohme v Wyeth
Regeneron & Teva v Rinat Neuroscience
Merck Sharp & Dohme v Pfizer
Postgraduate Diploma in Intellectual Property Law and Practice, University of Oxford (2016)
Qualified as a Solicitor in England & Wales (2015)
Legal Practice Course, University of Law, London (2013)
Graduate Diploma in Law, BPP Professional Education, London (2012)
BSc (Hons) Physics, University of Durham (2011)
Daniel McGrath is a Partner and Solicitor based in London who advises clients on a wide range of intellectual property matters, with a particular focus on contentious life sciences and high-tech work. He has particular experience in biopharmaceutical patent and SPC litigation and has represented clients in some of the most complex technical disputes tried in the English courts.
Qualified as a Solicitor in England & Wales in 2015, he has advised clients in proceedings before the High Court and Court of Appeal and has significant experience of multi-jurisdictional disputes involving teams across Europe, North America, Asia and Australia.
With a keen interest in scientific innovation, Dan is readily able to master highly technical issues and has a strong grasp of the technical and commercial landscape in which his clients operate.
Dan has particular experience in biopharmaceutical patent and SPC litigation. His life sciences work covers antibodies, vaccines, pharmaceutical formulations, small molecules and second medical use products. He also advises on regulatory matters including SPCs, SPCs for plant protection products, paediatric rewards and marketing authorisations.
In the high-tech sector, Dan advises on FRAND and standard essential patent issues, wireless communication systems, software and web technologies. He is recognised for his ability to work effectively with technically complex subject matter, helping clients navigate both the technical and commercial considerations relevant to their disputes and business objectives. His wider experience includes matters involving fire-rated downlights, zip and closure technologies, as well as trade marks, designs, copyright and confidential information.
Dan holds a Postgraduate Diploma in Intellectual Property Law and Practice from the University of Oxford (2016) and a BSc (Hons) in Physics from the University of Durham (2011). He joined Marks & Clerk Law in November 2016 after training and qualifying at a magic circle firm.
Key cases:
Sun Pharma and Almirall v Janssen Biotech
Chugai v UCB
Eli Lilly v Genentech
Merck Sharp & Dohme v Wyeth
Regeneron & Teva v Rinat Neuroscience
Merck Sharp & Dohme v Pfizer
Postgraduate Diploma in Intellectual Property Law and Practice, University of Oxford (2016)
Qualified as a Solicitor in England & Wales (2015)
Legal Practice Course, University of Law, London (2013)
Graduate Diploma in Law, BPP Professional Education, London (2012)
BSc (Hons) Physics, University of Durham (2011)